Skip to main content
Top
Published in: European Radiology 5/2011

01-05-2011 | Urogenital

Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: initial results

Authors: Sung Yoon Park, Chan Kyo Kim, Byung Kwan Park, Hyun Moo Lee, Kyung Soo Lee

Published in: European Radiology | Issue 5/2011

Login to get access

Abstract

Objective

To retrospectively assess the apparent diffusion coefficient (ADC) as a predictor of biochemical recurrence (BCR) after surgery in patients with localised prostate cancer.

Methods

Enrolled in this study were 158 men who underwent surgery between 2005 and 2007 with preoperative diffusion-weighted MR imaging (DWI) at 3 T, and who received follow-up for a median of 24 months (range, 12–57 months). Univariate and multivariate analyses including all clinical variables and tumour ADC data were performed with respect to BCR. Receiver operating characteristic (ROC) analysis was also performed to assess diagnostic performance of variables in the prediction of BCR.

Results

Thirty patients (19%) who received surgery had BCR. Univariate analysis revealed that tumour ADC, Gleason score at biopsy and surgical specimen, serum PSA, greatest percentage of cancer in biopsy core, percentage of positive cores in all biopsy cores and tumour volume were all significantly related to BCR. However, multivariate analysis identified tumour ADC as the only independently predictive factor. For predicting BCR, area under the curve for tumour ADC was 0.755, and tumour ADC showed better diagnostic performance than that of all other variables.

Conclusion

Tumour ADC on DWI may be a predictive biomarker for BCR following radical prostatectomy.
Literature
1.
go back to reference Heidenreich A, Aus G, Bolla M, Joniau S, Matveev VB, Schmid HP, Zattoni F (2008) EAU guidelines on prostate cancer. Eur Urol 53:68–80PubMedCrossRef Heidenreich A, Aus G, Bolla M, Joniau S, Matveev VB, Schmid HP, Zattoni F (2008) EAU guidelines on prostate cancer. Eur Urol 53:68–80PubMedCrossRef
2.
go back to reference Hull GW, Rabbani F, Abbas F, Wheeler TM, Kattan MW, Scardino PT (2002) Cancer control with radical prostatectomy alone in 1, 000 consecutive patients. J Urol 167:528–534PubMedCrossRef Hull GW, Rabbani F, Abbas F, Wheeler TM, Kattan MW, Scardino PT (2002) Cancer control with radical prostatectomy alone in 1, 000 consecutive patients. J Urol 167:528–534PubMedCrossRef
3.
go back to reference Walz J, Chun FK, Klein EA, Reuther A, Saad F, Graefen M, Huland H, Karakiewicz PI (2009) Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer. J Urol 181:601–607, discussion 607–608PubMedCrossRef Walz J, Chun FK, Klein EA, Reuther A, Saad F, Graefen M, Huland H, Karakiewicz PI (2009) Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer. J Urol 181:601–607, discussion 607–608PubMedCrossRef
4.
go back to reference Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Partin AW (2006) Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality. J Urol 176:1404–1408PubMedCrossRef Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Partin AW (2006) Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality. J Urol 176:1404–1408PubMedCrossRef
5.
go back to reference Shariat SF, Karakiewicz PI, Roehrborn CG, Kattan MW (2008) An updated catalog of prostate cancer predictive tools. Cancer 113:3075–3099PubMedCrossRef Shariat SF, Karakiewicz PI, Roehrborn CG, Kattan MW (2008) An updated catalog of prostate cancer predictive tools. Cancer 113:3075–3099PubMedCrossRef
6.
go back to reference Poulakis V, Witzsch U, de Vries R, Emmerlich V, Meves M, Altmannsberger HM, Becht E (2004) Preoperative neural network using combined magnetic resonance imaging variables, prostate specific antigen, and Gleason score to predict prostate cancer recurrence after radical prostatectomy. Eur Urol 46:571–578PubMedCrossRef Poulakis V, Witzsch U, de Vries R, Emmerlich V, Meves M, Altmannsberger HM, Becht E (2004) Preoperative neural network using combined magnetic resonance imaging variables, prostate specific antigen, and Gleason score to predict prostate cancer recurrence after radical prostatectomy. Eur Urol 46:571–578PubMedCrossRef
7.
go back to reference Kim CK, Park BK, Lee HM, Kwon GY (2007) Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3 T using a phased-array coil: preliminary results. Invest Radiol 42:842–847PubMedCrossRef Kim CK, Park BK, Lee HM, Kwon GY (2007) Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3 T using a phased-array coil: preliminary results. Invest Radiol 42:842–847PubMedCrossRef
8.
go back to reference Lim HK, Kim JK, Kim KA, Cho KS (2009) Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection–a multireader study. Radiology 250:145–151PubMedCrossRef Lim HK, Kim JK, Kim KA, Cho KS (2009) Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection–a multireader study. Radiology 250:145–151PubMedCrossRef
9.
go back to reference Beyersdorff D, Taymoorian K, Knosel T, Schnorr D, Felix R, Hamm B, Bruhn H (2005) MRI of prostate cancer at 1.5 and 3.0 T: comparison of image quality in tumor detection and staging. AJR Am J Roentgenol 185:1214–1220PubMedCrossRef Beyersdorff D, Taymoorian K, Knosel T, Schnorr D, Felix R, Hamm B, Bruhn H (2005) MRI of prostate cancer at 1.5 and 3.0 T: comparison of image quality in tumor detection and staging. AJR Am J Roentgenol 185:1214–1220PubMedCrossRef
10.
go back to reference Wang L, Zhang J, Schwartz LH, Eisenberg H, Ishill NM, Moskowitz CS, Scardino P, Hricak H (2007) Incremental value of multiplanar cross-referencing for prostate cancer staging with endorectal MRI. AJR Am J Roentgenol 188:99–104PubMedCrossRef Wang L, Zhang J, Schwartz LH, Eisenberg H, Ishill NM, Moskowitz CS, Scardino P, Hricak H (2007) Incremental value of multiplanar cross-referencing for prostate cancer staging with endorectal MRI. AJR Am J Roentgenol 188:99–104PubMedCrossRef
11.
go back to reference Wang L, Hricak H, Kattan MW, Schwartz LH, Eberhardt SC, Chen HN, Scardino PT (2006) Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer. AJR Am J Roentgenol 186:743–748PubMedCrossRef Wang L, Hricak H, Kattan MW, Schwartz LH, Eberhardt SC, Chen HN, Scardino PT (2006) Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer. AJR Am J Roentgenol 186:743–748PubMedCrossRef
12.
go back to reference deSouza NM, Riches SF, Vanas NJ, Morgan VA, Ashley SA, Fisher C, Payne GS, Parker C (2008) Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. Clin Radiol 63:774–782PubMedCrossRef deSouza NM, Riches SF, Vanas NJ, Morgan VA, Ashley SA, Fisher C, Payne GS, Parker C (2008) Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. Clin Radiol 63:774–782PubMedCrossRef
13.
go back to reference Tamada T, Sone T, Jo Y, Toshimitsu S, Yamashita T, Yamamoto A, Tanimoto D, Ito K (2008) Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade. J Magn Reson Imaging 28:720–726PubMedCrossRef Tamada T, Sone T, Jo Y, Toshimitsu S, Yamashita T, Yamamoto A, Tanimoto D, Ito K (2008) Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade. J Magn Reson Imaging 28:720–726PubMedCrossRef
14.
go back to reference van As NJ, de Souza NM, Riches SF, Morgan VA, Sohaib SA, Dearnaley DP, Parker CC (2008) A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance. Eur Urol van As NJ, de Souza NM, Riches SF, Morgan VA, Sohaib SA, Dearnaley DP, Parker CC (2008) A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance. Eur Urol
15.
go back to reference Guo AC, Cummings TJ, Dash RC, Provenzale JM (2002) Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 224:177–183PubMedCrossRef Guo AC, Cummings TJ, Dash RC, Provenzale JM (2002) Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 224:177–183PubMedCrossRef
16.
go back to reference Lyng H, Haraldseth O, Rofstad EK (2000) Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med 43:828–836PubMedCrossRef Lyng H, Haraldseth O, Rofstad EK (2000) Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med 43:828–836PubMedCrossRef
17.
go back to reference Cookson MS, Aus G, Burnett AL, Canby-Hagino ED, D’Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus SR, Moul JW, Tangen C, Thrasher JB, Thompson I (2007) Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 177:540–545PubMedCrossRef Cookson MS, Aus G, Burnett AL, Canby-Hagino ED, D’Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus SR, Moul JW, Tangen C, Thrasher JB, Thompson I (2007) Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 177:540–545PubMedCrossRef
18.
go back to reference Dhingsa R, Qayyum A, Coakley FV, Lu Y, Jones KD, Swanson MG, Carroll PR, Hricak H, Kurhanewicz J (2004) Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy. Radiology 230:215–220PubMedCrossRef Dhingsa R, Qayyum A, Coakley FV, Lu Y, Jones KD, Swanson MG, Carroll PR, Hricak H, Kurhanewicz J (2004) Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy. Radiology 230:215–220PubMedCrossRef
19.
go back to reference Higano S, Yun X, Kumabe T, Watanabe M, Mugikura S, Umetsu A, Sato A, Yamada T, Takahashi S (2006) Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology 241:839–846PubMedCrossRef Higano S, Yun X, Kumabe T, Watanabe M, Mugikura S, Umetsu A, Sato A, Yamada T, Takahashi S (2006) Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology 241:839–846PubMedCrossRef
20.
go back to reference Murakami R, Sugahara T, Nakamura H, Hirai T, Kitajima M, Hayashida Y, Baba Y, Oya N, Kuratsu J, Yamashita Y (2007) Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging. Radiology 243:493–499PubMedCrossRef Murakami R, Sugahara T, Nakamura H, Hirai T, Kitajima M, Hayashida Y, Baba Y, Oya N, Kuratsu J, Yamashita Y (2007) Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging. Radiology 243:493–499PubMedCrossRef
21.
go back to reference Tworek JA, Appelman HD, Singleton TP, Greenson JK (1997) Stromal tumors of the jejunum and ileum. Mod Pathol 10:200–209PubMed Tworek JA, Appelman HD, Singleton TP, Greenson JK (1997) Stromal tumors of the jejunum and ileum. Mod Pathol 10:200–209PubMed
22.
go back to reference Tworek JA, Goldblum JR, Weiss SW, Greenson JK, Appelman HD (1999) Stromal tumors of the abdominal colon: a clinicopathologic study of 20 cases. Am J Surg Pathol 23:937–945PubMedCrossRef Tworek JA, Goldblum JR, Weiss SW, Greenson JK, Appelman HD (1999) Stromal tumors of the abdominal colon: a clinicopathologic study of 20 cases. Am J Surg Pathol 23:937–945PubMedCrossRef
23.
go back to reference Kuwano H, Miyazaki T, Tsutsumi S, Hirayama I, Shimura T, Mochiki E, Nomoto K, Fukuchi M, Kato H, Asao T (2004) Cell density modulates the metastatic aggressiveness of a mouse colon cancer cell line, colon 26. Oncology 67:441–449PubMedCrossRef Kuwano H, Miyazaki T, Tsutsumi S, Hirayama I, Shimura T, Mochiki E, Nomoto K, Fukuchi M, Kato H, Asao T (2004) Cell density modulates the metastatic aggressiveness of a mouse colon cancer cell line, colon 26. Oncology 67:441–449PubMedCrossRef
24.
go back to reference May M, Knoll N, Siegsmund M, Fahlenkamp D, Vogler H, Hoschke B, Gralla O (2007) Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1, 296 patients. J Urol 178:1957–1962, discussion 1962PubMedCrossRef May M, Knoll N, Siegsmund M, Fahlenkamp D, Vogler H, Hoschke B, Gralla O (2007) Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1, 296 patients. J Urol 178:1957–1962, discussion 1962PubMedCrossRef
25.
go back to reference Stephenson AJ, Kattan MW, Eastham JA, Dotan ZA, Bianco FJ Jr, Lilja H, Scardino PT (2006) Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition. J Clin Oncol 24:3973–3978PubMedCrossRef Stephenson AJ, Kattan MW, Eastham JA, Dotan ZA, Bianco FJ Jr, Lilja H, Scardino PT (2006) Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition. J Clin Oncol 24:3973–3978PubMedCrossRef
26.
go back to reference Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J (1995) Long-term survival among men with conservatively treated localized prostate cancer. JAMA 274:626–631PubMedCrossRef Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J (1995) Long-term survival among men with conservatively treated localized prostate cancer. JAMA 274:626–631PubMedCrossRef
27.
go back to reference Potter SR, Miller MC, Mangold LA, Jones KA, Epstein JI, Veltri RW, Partin AW (1999) Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomy. Urology 54:791–795PubMedCrossRef Potter SR, Miller MC, Mangold LA, Jones KA, Epstein JI, Veltri RW, Partin AW (1999) Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomy. Urology 54:791–795PubMedCrossRef
28.
go back to reference Kattan MW, Wheeler TM, Scardino PT (1999) Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 17:1499–1507PubMed Kattan MW, Wheeler TM, Scardino PT (1999) Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 17:1499–1507PubMed
29.
go back to reference D’Amico AV, Whittington R, Malkowicz SB, Fondurulia J, Chen MH, Tomaszewski JE, Wein A (1998) The combination of preoperative prostate specific antigen and postoperative pathological findings to predict prostate specific antigen outcome in clinically localized prostate cancer. J Urol 160:2096–2101PubMedCrossRef D’Amico AV, Whittington R, Malkowicz SB, Fondurulia J, Chen MH, Tomaszewski JE, Wein A (1998) The combination of preoperative prostate specific antigen and postoperative pathological findings to predict prostate specific antigen outcome in clinically localized prostate cancer. J Urol 160:2096–2101PubMedCrossRef
30.
go back to reference Schaefer PW, Grant PE, Gonzalez RG (2000) Diffusion-weighted MR imaging of the brain. Radiology 217:331–345PubMed Schaefer PW, Grant PE, Gonzalez RG (2000) Diffusion-weighted MR imaging of the brain. Radiology 217:331–345PubMed
31.
go back to reference Riches SF, Hawtin K, Charles-Edwards EM, de Souza NM (2009) Diffusion-weighted imaging of the prostate and rectal wall: comparison of biexponential and monoexponential modelled diffusion and associated perfusion coefficients. NMR Biomed 22:318–325PubMedCrossRef Riches SF, Hawtin K, Charles-Edwards EM, de Souza NM (2009) Diffusion-weighted imaging of the prostate and rectal wall: comparison of biexponential and monoexponential modelled diffusion and associated perfusion coefficients. NMR Biomed 22:318–325PubMedCrossRef
Metadata
Title
Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: initial results
Authors
Sung Yoon Park
Chan Kyo Kim
Byung Kwan Park
Hyun Moo Lee
Kyung Soo Lee
Publication date
01-05-2011
Publisher
Springer-Verlag
Published in
European Radiology / Issue 5/2011
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-010-1999-9

Other articles of this Issue 5/2011

European Radiology 5/2011 Go to the issue